Item 5.03. Amendments to Articles of Incorporation or Bylaws; Change in Fiscal


           Year.

On September 9, 2022, Invivyd, Inc. (the "Company") filed a certificate of amendment (the "Certificate of Amendment") to its Amended and Restated Certificate of Incorporation with the Secretary of State of the State of Delaware solely to change the Company's name from "Adagio Therapeutics, Inc." to "Invivyd, Inc." The name change became effective on September 13, 2022. A copy of the Certificate of Amendment is attached as Exhibit 3.1 hereto and incorporated herein by reference.

In connection with the name change, the Company's Board of Directors amended the Company's Amended and Restated Bylaws (the "Bylaws") to reflect the Company's name change, also effective September 13, 2022. No other changes were made to the Bylaws. A copy of the Bylaws reflecting this amendment is attached as Exhibit 3.2 hereto and incorporated herein by reference.

The Company's common stock previously traded on the Nasdaq Global Market under the ticker symbol "ADGI" and, effective as of September 13, 2022, is trading on the Nasdaq Global Market under the new ticker symbol "IVVD."

The name change does not affect the rights of the Company's security holders, and the CUSIP number for the Company's common stock will continue to be 00534A102.

Item 9.01. Financial Statements and Exhibits.




(d) Exhibits

Exhibit
  No.       Description

 3.1          Certificate of Amendment to Amended and Restated Certificate of
            Incorporation

 3.2          Amended and Restated Bylaws

104         Cover Page Interactive Data File (embedded within the Inline XBRL
            document)

--------------------------------------------------------------------------------

© Edgar Online, source Glimpses